Compare PSNL & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSNL | NFJ |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2019 | N/A |
| Metric | PSNL | NFJ |
|---|---|---|
| Price | $13.89 | $15.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.20 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 191.4K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.01% |
| EPS Growth | ★ 33.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,648,000.00 | N/A |
| Revenue This Year | $15.34 | N/A |
| Revenue Next Year | $41.46 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.45 | $12.25 |
| 52 Week High | $16.39 | $15.73 |
| Indicator | PSNL | NFJ |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 69.04 |
| Support Level | $6.89 | $14.87 |
| Resistance Level | $14.81 | N/A |
| Average True Range (ATR) | 0.59 | 0.16 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 79.03 | 98.31 |
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. It pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.